Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
Characterization Of CXCR4 Protein
[0109] Based on the known topology of 7-transmembrane segment proteins, four regions of CXCR4 are predicted to be exposed at the cell surface. Synthetic peptides are synthesized by methods well-known in the art that correspond to each of these 4 regions. Rabbit antisera is raised by immunization with peptide-KLH (keyhole limpet hemocyanin) conjugates. Total immunoglobulin is purified from the preimmune and the immune sera by chromatographic separation with Protein-A Sepharose.
[0110] Antibodies raised against the 38 amino acid N-terminal portion of CXCR4 blocked membrane fusion between the env-positive, LAV isolate of HIV-1, and CD4-positive, primary T cells. In contrast, antibodies raised against other peptide-KLH conjugates had no effect of membrane fusion between the virus and the target cells.
example 2
CXCR4-Mediated Inhibition of Viral Fusion
[0111] The sensitivity of fusion mediate by env from different HIV isolates was tested using antibodies against the N-terminal portion of CXCR4. FIG. 2 shows that these anti-CXCR4 antibodies inhibited fusion mediated by the prototypic T cell line-tropic LAV env, but did not inhibit fusion mediated by the prototypic macrophage-tropic Ba-L env. These results indicate that the fusion inhibition with anti-CXCR4 antibodies is not due to nonspecific inhibitory effects on the cells. Table 3 demonstrates that coexpression of CXCR4 enhanced fusion much more with env from T cell line-tropic isolates (IIIB, LAV, and RF) as compared with env from macrophage-tropic strains (Ba-L, SF162, JR-FL, and ADA).
[0112] Although the invention has been described with reference to the presently preferred embodiment, it should be understood that various modifications can be made without departing from the spirit of the invention. Accordingly, the invention is limited...
PUM
Property | Measurement | Unit |
---|---|---|
Dimensionless property | aaaaa | aaaaa |
Dimensionless property | aaaaa | aaaaa |
Pharmaceutically acceptable | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com